EARNINGS PER SHARE (Tables)

3 Months Ended

Mar. 31, 2018

Schedule of Earnings Per Share, Basic and Diluted

The components of basic and diluted earnings per share are as follows:



	For the Three Months Ended March 31,
	2018			2017
Income / (loss) from continuing operations	$	6,084		$	(5,982	)
Net loss attributable to noncontrolling interests	178			209
Less: preferred share accretion paid in kind (Note 13)	(2,447		)	(2,357		)
Less: income allocated to Series B Preferred Shares	(1,563		)	—
Income / (loss) from continuing operations available to common shareholders, net of noncontrolling interest	2,252			(8,130		)
Income / (loss) from discontinued operations, net of tax (Note 3)	988			(5,292		)
Net income / (loss) attributable to CME Ltd. available to common shareholders — basic	3,240			(13,422		)

Effect of dilutive securities
Dilutive effect of Series B Preferred Shares	65			—
Net income / (loss) attributable to CME Ltd. available to common shareholders — diluted	$	3,305		$	(13,422	)

Weighted average outstanding shares of common stock — basic ⁽¹⁾	158,039			154,795
Dilutive effect of common stock warrants, employee stock options and RSUs	83,866			—
Weighted average outstanding shares of common stock — diluted	241,905			154,795

Net income / (loss) per share:
Continuing operations — basic	$	0.01		$	(0.05	)
Continuing operations — diluted	0.01			(0.05		)
Discontinued operations — basic	0.01			(0.04		)
Discontinued operations — diluted	0.00			(0.04		)
Net income / (loss) attributable to CME Ltd. — basic	0.02			(0.09		)
Net income / (loss) attributable to CME Ltd. — diluted	0.01			(0.09		)

⁽¹⁾

For the purpose of computing basic earnings per share, the 11,211,449 shares of Class A common stock underlying the Series A Preferred Share are included in the weighted average outstanding shares of common stock - basic, because the holder of the Series A Preferred Share is entitled to receive any dividends payable when dividends are declared by the Board of Directors with respect to any shares of the common stock.

Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share

The following weighted-average, equity awards and convertible shares were excluded from the calculation of diluted earnings per share because their effect would have been anti-dilutive for the periods presented:



	For the Three Months Ended March 31,
	2018	2017
Employee stock options	—	2,011
RSUs	903	1,176
Series B Preferred Shares	—	105,658
Total	903	108,845

These instruments may become dilutive in the future. As set forth in the Certificate of Designation for the Series B Preferred Shares, the holders of our Series B Preferred Shares are not contractually obligated to share in our losses.